Stay updated on DKRd in Newly Diagnosed Myeloma Clinical Trial
Sign up to get notified when there's something new on the DKRd in Newly Diagnosed Myeloma Clinical Trial page.

Latest updates to the DKRd in Newly Diagnosed Myeloma Clinical Trial page
- Check2 days agoChange DetectedThe footer’s site revision identifier changed from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check9 days agoChange DetectedThe clinical trial record for a Phase 2 study of D-KRd in newly diagnosed multiple myeloma is now displayed, including its treatment plan, eligibility criteria, outcome measures, and study status.SummaryDifference56%

- Check16 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check30 days agoChange DetectedA sitewide banner announces an NIH website terminology transition, and the site revision advances from v3.7.1 to v3.7.2. The page continues to show a 403 error instead of the study record.SummaryDifference1%

- Check44 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check58 days agoChange DetectedThe study page now shows a 403 Forbidden error, preventing access to the study record. This blocks viewing the trial details and related information on the page.SummaryDifference20%

Stay in the know with updates to DKRd in Newly Diagnosed Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DKRd in Newly Diagnosed Myeloma Clinical Trial page.